Hjem › Blodpropper › Louisiana
Blodpropper kliniske forsøg i Louisiana
7 studier for Blodpropper søger deltagere på steder i Louisiana.
Byer i Louisiana
Officiel studietekst (engelsk)
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Monroe Research, LLC, West Monroe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07626411Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Monroe Research, LLC, West Monroe
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07175428Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
- CIS Clinical Research, Houma
RekruttererFase 2
Alder 18 til 89 · Alle køn · Opdateret 25. sep. 2026 · NCT04862468Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
- Cardiovascular Solutions, Shreveport
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07318610Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Monroe Research, LLC, West Monroe
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07430956ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Louisiana Center for Bleeding and Clotting Disorders, Tulane University, New Orleans
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 17. aug. 2026 · NCT04398628The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study
- East Jefferson General Hospital, New Orleans
- University Medical Center, New Orleans
- Tulane Doctors - Speciality Care - Napoleon, New Orleans
RekruttererObservationsstudie
Alder 18 til 120 · Alle køn · Opdateret 5. mar. 2026 · NCT04947657Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.